HomeCompareABC vs CHD

ABC vs CHD: Dividend Comparison 2026

ABC yields 1.08% · CHD yields 1.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ABC wins by $4.5K in total portfolio value· pulled ahead in Year 3
10 years
ABC
ABC
● Live price
1.08%
Share price
$179.98
Annual div
$1.94
5Y div CAGR
34.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.8K
Annual income
$2,940.21
Full ABC calculator →
CHD
CHD
● Live price
1.27%
Share price
$93.91
Annual div
$1.19
5Y div CAGR
23.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.4K
Annual income
$1,292.51
Full CHD calculator →

Portfolio growth — ABC vs CHD

📍 ABC pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodABCCHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ABC + CHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ABC pays
CHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ABC
Annual income on $10K today (after 15% tax)
$91.62/yr
After 10yr DRIP, annual income (after tax)
$2,499.18/yr
CHD
Annual income on $10K today (after 15% tax)
$107.94/yr
After 10yr DRIP, annual income (after tax)
$1,098.63/yr
At 15% tax rate, ABC beats the other by $1,400.55/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ABC + CHD for your $10,000?

ABC: 50%CHD: 50%
100% CHD50/50100% ABC
Portfolio after 10yr
$28.6K
Annual income
$2,116.35/yr
Blended yield
7.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABC right now

ABC
Analyst Ratings
20
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$171.00
-5.0% upside vs current
Range: $150.00 — $190.00
Altman Z
4.6
Piotroski
6/9
CHD
Analyst Ratings
18
Buy
15
Hold
1
Sell
Consensus: Buy
Price Target
$98.40
+4.8% upside vs current
Range: $82.00 — $110.00
Altman Z
4.9
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ABC buys
3
CHD buys
0
PoliticianChamberTickerTypeAmountDate
Tommy Tuberville🏛 Senate$ABC▼ Sell$15,001 - $50,0002022-01-21
Tommy Tuberville🏛 Senate$ABC▼ Sell$15,001 - $50,0002022-01-21
Michael McCaul🏢 House$ABC▲ Buy$50,001 - $100,0002021-03-01
Michael McCaul🏢 House$ABC▲ Buy$50,001 - $100,0002021-03-01
Gilbert Cisneros🏢 House$ABC▼ Sell$1,001 - $15,0002019-05-09
Pete Sessions🏢 House$ABC▼ Sell$15,001 - $50,0002017-11-27
Thomas Suozzi🏢 House$ABC▼ Sell$15,001 - $50,0002017-01-05
Pete Sessions🏢 House$ABC▲ Buy$15,001 - $50,0002015-07-31
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricABCCHD
Forward yield1.08%1.27%
Annual dividend / share$1.94$1.19
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR34.4%23.1%
Portfolio after 10y$30.8K$26.4K
Annual income after 10y$2,940.21$1,292.51
Total dividends collected$9.6K$5.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy
Analyst price target$171.00$98.40

Year-by-year: ABC vs CHD ($10,000, DRIP)

YearABC PortfolioABC Income/yrCHD PortfolioCHD Income/yrGap
1$10,845$144.87$10,856$156.32$11.00CHD
2$11,801$197.34$11,811$195.24$10.00CHD
3← crossover$12,897$269.74$12,883$244.38+$14.00ABC
4$14,170$370.27$14,091$306.64+$79.00ABC
5$15,673$510.99$15,463$385.88+$210.00ABC
6$17,480$709.92$17,033$487.17+$447.00ABC
7$19,698$994.53$18,843$617.36+$855.00ABC
8$22,485$1,407.72$20,947$785.72+$1.5KABC
9$26,077$2,018.33$23,419$1,004.91+$2.7KABC
10$30,843$2,940.21$26,350$1,292.51+$4.5KABC

ABC vs CHD: Complete Analysis 2026

ABCStock

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Full ABC Calculator →

CHDConsumer Staples

Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.

Full CHD Calculator →
📬

Get this ABC vs CHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ABC vs SCHDABC vs JEPIABC vs OABC vs KOABC vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.